← Eichor
Study identifier: NCT06759402 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Family-based Telemedicine vs. Inpatient Anorexia Nervosa Treatment (FIAT)

Condition: Anorexia Nervosa · Anorexia in Adolescence  ·  Sponsor: Charite University, Berlin, Germany

PhaseNA
Planned participants200
Who can joinAll sexes, 8 Years to 17 Years
Healthy volunteersNo

About this study

The FIAT study is funded by the Innovationsfonds of the German Ministry of Health via the DLR Project Management Agency. The study will be conducted in up to 21 hospitals across Germany and in collaboration with 10 German public health insurance companies. The primary aim of this study is to compare Family-Based Treatment delivered via telehealth (FBT) with inpatient multimodal therapy (IMT) with respect to treatment outcomes and health economic data. The results of the study will serve as a basis for the decision on the inclusion of FBT in the German S3 guidelines and the future reimbursement of FBT by public health insurances in Germany.

This description comes directly from the study's public registry record.

Talk to the study team

Verena K. Haas, Dr. oec. troph.  ·  +4930 450 566 399  ·  verena.haas@charite.de

Piet E. Adler, M.Sc.  ·  +4930 450 566 597  ·  piet.adler@charite.de

Always discuss trial participation with your own doctor first.

Locations (1)

Charité- Universitätsmedizin BerlinBerlin, State of Berlin, GermanyRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06759402